Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
methylprednisolone (medrol) (1 trial)
rituximab (rituxan) (1 trial)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Chronic Progressive (Phase 2)
Nervous System Diseases (Phase 2)
Sclerosis (Phase 2)
Trials (1 total)
Trial APIs (2 total)